Please use this identifier to cite or link to this item:
doi:10.22028/D291-36904 | Title: | IL-17 Cytokines and Chronic Lung Diseases |
| Author(s): | Ritzmann, Felix Lunding, Lars Peter Bals, Robert Wegmann, Michael Beisswenger, Christoph |
| Language: | English |
| Title: | Cells |
| Volume: | 11 |
| Issue: | 14 |
| Publisher/Platform: | MDPI |
| Year of Publication: | 2022 |
| Free key words: | IL-17 lung diseases inflammation lung damage infection |
| DDC notations: | 610 Medicine and health |
| Publikation type: | Journal Article |
| Abstract: | IL-17 cytokines are expressed by numerous cells (e.g., gamma delta (γδ) T, innate lymphoid (ILC), Th17, epithelial cells). They contribute to the elimination of bacteria through the induction of cytokines and chemokines which mediate the recruitment of inflammatory cells to the site of infection. However, IL-17-driven inflammation also likely promotes the progression of chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, and asthma. In this review, we highlight the role of IL-17 cytokines in chronic lung diseases. |
| DOI of the first publication: | 10.3390/cells11142132 |
| Link to this record: | urn:nbn:de:bsz:291--ds-369040 hdl:20.500.11880/33597 http://dx.doi.org/10.22028/D291-36904 |
| ISSN: | 2073-4409 |
| Date of registration: | 8-Aug-2022 |
| Faculty: | M - Medizinische Fakultät |
| Department: | M - Innere Medizin |
| Professorship: | M - Prof. Dr. Robert Bals |
| Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
| File | Description | Size | Format | |
|---|---|---|---|---|
| cells-11-02132-v2.pdf | 4,22 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
